Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.67B | 10.69B | 11.39B | 12.07B | 12.61B | 15.30B |
Gross Profit | 3.40B | 3.86B | 3.06B | 3.09B | 3.95B | 5.58B |
EBITDA | -1.02B | 3.96B | -2.34B | -1.22B | -965.00M | 739.00M |
Net Income | 1.79B | 3.62B | -2.91B | -1.86B | -1.77B | -79.00M |
Balance Sheet | ||||||
Total Assets | 17.93B | 18.54B | 17.93B | 19.36B | 21.68B | 23.21B |
Cash, Cash Equivalents and Short-Term Investments | 9.64B | 10.14B | 6.56B | 7.01B | 9.49B | 10.51B |
Total Debt | 7.00M | 6.00M | 231.00M | 95.00M | 42.00M | 23.00M |
Total Liabilities | 3.05B | 3.12B | 5.99B | 4.60B | 4.72B | 4.33B |
Stockholders Equity | 14.88B | 15.42B | 11.94B | 14.76B | 16.97B | 18.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 204.00M | -1.09B | -2.71B | -720.00M | 360.00M |
Operating Cash Flow | 0.00 | 346.00M | -918.00M | -2.41B | -365.00M | 667.00M |
Investing Cash Flow | 0.00 | 3.25B | 781.00M | 137.00M | -398.00M | -323.00M |
Financing Cash Flow | 0.00 | -4.00M | -110.00M | -190.00M | -301.00M | -886.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥44.82B | 12.40 | 5.79% | 3.23% | -22.14% | ||
80 Outperform | ¥4.15B | 4.00 | ― | 3.30% | 36.77% | ||
68 Neutral | $8.11B | 2.27 | 25.99% | ― | -6.10% | ― | |
62 Neutral | ¥3.97B | 16.74 | 1.93% | -4.02% | -65.53% | ||
58 Neutral | ¥6.12B | 28.81 | 3.02% | -1.17% | ― | ||
57 Neutral | HK$25.53B | 4.08 | -2.03% | 6.14% | -0.31% | -67.64% | |
53 Neutral | ¥9.48B | 56.74 | 1.72% | -4.63% | -83.79% |